A detailed history of Orion Portfolio Solutions, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Orion Portfolio Solutions, LLC holds 9,758 shares of SRPT stock, worth $1.35 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
9,758
Previous 9,935 1.78%
Holding current value
$1.35 Million
Previous $1.57 Million 22.37%
% of portfolio
0.01%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$124.33 - $156.75 $22,006 - $27,744
-177 Reduced 1.78%
9,758 $1.22 Million
Q2 2024

Aug 13, 2024

SELL
$113.33 - $163.85 $18,246 - $26,379
-161 Reduced 1.59%
9,935 $1.57 Million
Q1 2024

May 09, 2024

BUY
$93.7 - $141.53 $292,625 - $441,998
3,123 Added 44.79%
10,096 $1.31 Million
Q4 2023

Feb 09, 2024

SELL
$67.31 - $124.76 $483,487 - $896,151
-7,183 Reduced 50.74%
6,973 $672,000
Q3 2023

Nov 01, 2023

BUY
$102.5 - $123.59 $122,795 - $148,060
1,198 Added 9.25%
14,156 $1.72 Million
Q2 2023

Aug 14, 2023

BUY
$106.4 - $157.19 $924,296 - $1.37 Million
8,687 Added 203.39%
12,958 $1.48 Million
Q1 2023

Aug 30, 2023

SELL
$117.53 - $155.99 $1.02 Million - $1.36 Million
-8,687 Reduced 67.04%
4,271 $588,000
Q1 2023

May 15, 2023

BUY
$117.53 - $155.99 $501,970 - $666,233
4,271 New
4,271 $588,000
Q3 2020

Nov 13, 2020

SELL
$127.12 - $172.34 $4,830 - $6,548
-38 Closed
0 $0
Q2 2020

Aug 19, 2020

SELL
$93.0 - $171.7 $2,325 - $4,292
-25 Reduced 39.68%
38 $6,000
Q1 2020

May 15, 2020

BUY
$82.38 - $131.64 $2,553 - $4,080
31 Added 96.88%
63 $6,000
Q4 2019

Feb 14, 2020

BUY
$76.53 - $135.58 $2,448 - $4,338
32 New
32 $4,000

Others Institutions Holding SRPT

About Sarepta Therapeutics, Inc.


  • Ticker SRPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,567,904
  • Market Cap $12.1B
  • Description
  • Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...
More about SRPT
Track This Portfolio

Track Orion Portfolio Solutions, LLC Portfolio

Follow Orion Portfolio Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orion Portfolio Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orion Portfolio Solutions, LLC with notifications on news.